Avalo Therapeutics (AVTX) Institutional Ownership → Millionaire investor and Republican donor makes surprising election prediction (From InvestorPlace) (Ad) Free AVTX Stock Alerts $10.97 +0.12 (+1.11%) (As of 03:00 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Avalo Therapeutics (NASDAQ:AVTX)CurrentInstitutional OwnershipPercentage87.06%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$228.87MNumber ofInstitutional Sellers(last 12 months)0 Get AVTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Avalo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data AVTX Institutional Buying and Selling by Quarter Ad Insiders ExposedThis consistently signaled gains of 453%... 610%... and even 1036%...It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.Register for the imminent briefing here. Avalo Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/13/2023Acadian Asset Management LLC283,306$34K0.0%N/A1.399% 8/11/2023VR Adviser LLC1,250,000$444K0.1%+25.0%6.173% 5/16/2023Great Point Partners LLC474,639$831K0.2%N/A3.595% 5/5/2023Monashee Investment Management LLC60,000$105K0.0%N/A0.455% 2/15/2023Nantahala Capital Management LLC540,667$2.73M0.2%-1.3%5.746% 11/14/2022Armistice Capital LLC3,964,666$13.16M0.2%-91.7%42.115% Get the Latest News and Ratings for AVTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/14/2022Point72 Asset Management L.P.500,737$1.66M0.0%-91.7%5.319% 11/10/2022Nantahala Capital Management LLC547,814$1.82M0.1%-91.8%5.819% 10/27/2022 Assenagon Asset Management S.A.15,646$52K0.0%N/A0.166% 8/15/2022Nantahala Capital Management LLC6,710,327$3.36M0.2%-2.0%71.280% 8/15/2022Opaleye Management Inc.450,000$225K0.1%-69.1%4.780% 5/12/2022Integral Health Asset Management LLC700,000$507K0.1%-56.9%0.621% 5/3/2022Leo Brokerage LLC62,629$45K0.0%N/A0.056% 4/25/2022 Assenagon Asset Management S.A.42,338$31K0.0%-92.7%0.038% 2/15/2022Stonepine Capital Management LLC1,510,095$2.57M1.2%+77.7%1.344% 2/15/2022 LGL Partners LLC28,850$49K0.0%N/A0.026% 2/14/2022Freestone Capital Holdings LLC20,000$34K0.0%N/A0.018% 2/14/2022Soleus Capital Management L.P.770,000$1.31M0.1%N/A0.686% 2/8/2022Northern Trust Corp533,578$907K0.0%+3.1%0.475% 2/1/2022 Assenagon Asset Management S.A.582,718$991K0.0%-33.7%0.519% 1/24/2022Strs Ohio38,400$65K0.0%-40.2%0.034% 1/20/2022Minot Wealth Management LLC34,645$59K0.0%-66.5%0.031% 12/29/2021Hudson Bay Capital Management LP197,133$430K0.0%N/A0.176% 11/16/2021Opaleye Management Inc.1,459,400$3.18M0.6%N/A1.299% 11/16/2021Squarepoint Ops LLC18,657$41K0.0%N/A0.017% 11/16/2021Two Sigma Advisers LP801,300$1.75M0.0%N/A0.713% 11/16/2021Two Sigma Investments LP732,931$1.60M0.0%N/A0.653% 11/16/2021Laurion Capital Management LP330,444$720K0.0%N/A0.294% 11/15/2021Point72 Asset Management L.P.6,008,850$13.10M0.1%N/A5.350% 11/15/2021Atom Investors LP27,507$60K0.0%N/A0.024% 11/15/2021Voya Investment Management LLC21,854$48K0.0%N/A0.019% 11/15/2021 Caas Capital Management LP11,812$26K0.0%N/A0.011% 11/12/2021Aristides Capital LLC48,953$107K0.0%N/A0.044% 11/12/2021Stonepine Capital Management LLC850,000$1.85M0.8%N/A0.770% 11/12/2021Geode Capital Management LLC1,242,382$2.71M0.0%N/A1.126% 11/12/2021Integral Health Asset Management LLC1,625,000$3.54M1.0%N/A1.473% 11/10/2021Goldman Sachs Group Inc.672,664$1.47M0.0%N/A0.610% 11/10/2021Creative Planning14,814$32K0.0%N/A0.013% 11/10/2021Alliancebernstein L.P.19,100$42K0.0%N/A0.017% 11/9/2021BlackRock Inc.3,716,943$8.10M0.0%N/A3.369% Free report reveals “two-baggers” for 2024 (Ad)We’ve put together something special for our subscribers — a free report on 5 stocks we believe could double in 2024. It’s straightforward, easy to understand, and most importantly, actionable.Download your free report today!11/9/2021Monashee Investment Management LLC270,000$589K0.1%N/A0.245% 11/8/2021 Meeder Asset Management Inc.19,260$43K0.0%N/A0.017% 11/4/2021Asymmetry Capital Management L.P.534,621$1.17M0.7%N/A0.485% 11/4/2021Deutsche Bank AG31,794$69K0.0%N/A0.029% 11/2/2021 Cambridge Investment Research Advisors Inc.12,164$27K0.0%N/A0.011% 11/2/2021 New York State Common Retirement Fund22,214$48K0.0%N/A0.020% 11/2/2021 Victory Capital Management Inc.15,788$34K0.0%N/A0.014% 11/1/2021 SG Americas Securities LLC18,596$41K0.0%N/A0.017% 10/29/2021Commonwealth Equity Services LLC52,000$113K0.0%N/A0.047% 10/25/2021Minot Wealth Management LLC103,410$225K0.0%N/A0.094% 10/22/2021Strs Ohio64,200$139K0.0%N/A0.058% 10/19/2021 Assenagon Asset Management S.A.879,334$1.92M0.0%N/A0.797% 10/19/2021Tamar Securities LLC23,084$50K0.0%N/A0.021% (Data available from 1/1/2016 forward) AVTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of AVTX shares? During the previous two years, 9 institutional investors and hedge funds held shares of Avalo Therapeutics. The most heavily invested institutionals were Armistice Capital LLC ($13.16M), Nantahala Capital Management LLC ($2.73M), Point72 Asset Management L.P. ($1.66M), Great Point Partners LLC ($831K), VR Adviser LLC ($444K), Opaleye Management Inc. ($225K), and Monashee Investment Management LLC ($105K).Learn more on AVTX's institutional investors. What percentage of Avalo Therapeutics stock is owned by institutional investors? 87.06% of Avalo Therapeutics stock is owned by institutional investors. Learn more on AVTX's institutional investor holdings. Which institutional investors have been buying Avalo Therapeutics stock? The following institutional investors have purchased Avalo Therapeutics stock in the last 24 months: Great Point Partners LLC ($474.64K), Acadian Asset Management LLC ($283.31K), VR Adviser LLC ($250K), Monashee Investment Management LLC ($60K), and Assenagon Asset Management S.A. ($15.65K). How much institutional buying is happening at Avalo Therapeutics? Institutional investors have bought a total of 1,083,591 shares in the last 24 months. This purchase volume represents approximately $266.53M in transactions. Which Avalo Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Avalo Therapeutics stock in the last 24 months: Armistice Capital LLC ($43.61M), Nantahala Capital Management LLC ($6.31M), Point72 Asset Management L.P. ($5.51M), and Opaleye Management Inc. ($1.00M). How much institutional selling is happening at Avalo Therapeutics? Institutional investors have sold a total of 56,432,727 shares in the last 24 months. This volume of shares sold represents approximately $45.70B in transactions. Related Companies: RedHill Biopharma Institutional Ownership Pieris Pharmaceuticals Institutional Ownership Monopar Therapeutics Institutional Ownership Kiora Pharmaceuticals Institutional Ownership Purple Biotech Institutional Ownership FSD Pharma Institutional Ownership Edesa Biotech Institutional Ownership Elevai Labs Institutional Ownership Akari Therapeutics Institutional Ownership Moleculin Biotech Institutional Ownership This page (NASDAQ:AVTX) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersDoes this make you sick?Allegiance GoldThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorObama’s Forever Term [exposed]Porter & CompanyUrgent Nvidia WarningAltimetryThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avalo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.